Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar with Paclitaxel and Carboplatin in Chemonaive Stage IIIB-IV NSCLC
NCT00558636Phase 3Terminated
- Sponsor
- Bayer
- Start
- Sep 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of sorafenib in non-small cell lung cancer (NSCLC), sponsored by Bayer. Started Sep 2007; status: terminated.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00558636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558636.